FDA Inspection 1290038 — Ablexan Corporation

Ablexan Corporation — FEI 3007798534

The FDA completed an inspection of Ablexan Corporation on October 29, 2025 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 29, 2025
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Raleigh, NC (United States)